Impact de la pandémie à COVID-19 sur la prise en charge thérapeutique des patients présentant une polyarthrite rhumatoïde en Bretagne (France)
- PMID: 34335020
- PMCID: PMC8314872
- DOI: 10.1016/j.rhum.2021.07.007
Impact de la pandémie à COVID-19 sur la prise en charge thérapeutique des patients présentant une polyarthrite rhumatoïde en Bretagne (France)
References
-
- Richez C., Flipo R.-M., Berenbaum F., Cantagrel A., Claudepierre P., Debiais F., et al. Managing patients with rheumatic diseases during the COVID-19 pandemic: the French Society of Rheumatology answers to most frequently asked questions up to May 2020. Joint Bone Spine. 2020;87:431–437. doi: 10.1016/j.jbspin.2020.05.006. - DOI - PMC - PubMed
-
- Quartuccio L., Valent F., Pasut E., Tascini C., De Vita S. Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: a population-based study in the first two months of COVID-19 outbreak in Italy. Joint Bone Spine. 2020;87:439–443. - PMC - PubMed
LinkOut - more resources
Full Text Sources